Detalles
This document provides additional guidance in the pharmaceutical and biotechnology sector. This covers: The assessment of nature-related issues using the TNFD's LEAP approach and the disclosure of sector-specific metrics in line with the approach recommended by the TNFD.
Recursos relacionados
Analysis of Best Practices in Environmental Disclosure Policies
There is a growing focus on the need to direct capital effectively and quickly towards sustainable solutions. However, key questions…
Recommendations of the Taskforce on Nature-related Financial Disclosures
This document provides the Final Recommendations of the TNFD. It includes a set of general requirements for nature-related disclosures and…
2023
Nota de la IEEB sobre los Resultados de la COP15 relevantes para el Sector Privado
Nota de enero 2023 eleborada por el secretariado de la IEEB sobre los resultados más relevantes para el sector privado…